The Federal Trade Commission in collaboration with the Food and Drug Administration held a public workshop, "FDA/FTC Workshop on a Competitive Marketplace for Biosimilars." The purpose of the public workshop was to discuss FDA and FTC’s collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading statements about biosimilars, and deter anticompetitive behaviors in the biologic marketplace.
Location: White Oak Campus: The Great Room, Conference Center, 10903 New Hampshire Ave, Building 31, Room 1503, Silver Spring, MD 20993
- Event webpage (FDA)
- Joint Policy Statement (Feb. 3, 2020)
- Press Release (Feb. 3, 2020)
- Opening Remarks of Chairman Joseph Simons (Mar. 9, 2020)
Transcript - Files